About the Authors
- Bruce A. Perkins
-
Contributed equally to this work with: Bruce A. Perkins, David Z. I. Cherney, Nima Soleymanlou
* E-mail: bperkins@mtsinai.on.ca
Affiliations Department of Medicine, Division of Endocrinology and Metabolism, University of Toronto, Toronto, ON, Canada, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, ON, Canada
- David Z. I. Cherney
-
Contributed equally to this work with: Bruce A. Perkins, David Z. I. Cherney, Nima Soleymanlou
Affiliation Department of Medicine, Division of Nephrology, Toronto General Hospital, University Health Network, University of Toronto, Toronto, ON, Canada
- Nima Soleymanlou
-
Contributed equally to this work with: Bruce A. Perkins, David Z. I. Cherney, Nima Soleymanlou
Affiliation Boehringer Ingelheim Canada Ltd./Ltée, Burlington, ON, Canada
- Justin A. Lee
-
Affiliation Department of Medicine, Division of Endocrinology and Metabolism, University of Toronto, Toronto, ON, Canada
- Helen Partridge
-
Affiliation Department of Medicine, Division of Endocrinology and Metabolism, University of Toronto, Toronto, ON, Canada
- Holly Tschirhart
-
Affiliation Department of Medicine, Division of Endocrinology and Metabolism, University of Toronto, Toronto, ON, Canada
- Bernard Zinman
-
Affiliations Department of Medicine, Division of Endocrinology and Metabolism, University of Toronto, Toronto, ON, Canada, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, ON, Canada
- Roger Mazze
-
Affiliation WHO Collaborating Center, Minneapolis, Minnesota, United States of America
- Nora Fagan
-
Affiliation Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, Connecticut, United States of America
- Stefan Kaspers
-
Affiliation Boehringer Ingelheim Pharma GmbH & Co.KG, Ingelheim, Germany
- Hans-Juergen Woerle
-
Affiliation Boehringer Ingelheim Pharma GmbH & Co.KG, Ingelheim, Germany
- Uli C. Broedl
-
Affiliation Boehringer Ingelheim Pharma GmbH & Co.KG, Ingelheim, Germany
- Odd Erik Johansen
-
Affiliation Boehringer Ingelheim Norway K.S, Asker, Norway
Competing Interests
BAP has received speaker honoraria from Medtronic Inc., Johnson and Johnson, Roche, GlaxoSmithKline Canada, Novo Nordisk and Sanofi; has received research grant support from Medtronic and Boehringer Ingelheim; and serves as a consultant for Neurometrix. DZC has received speaker honoraria from Merck, Boehringer Ingelheim, Janssen, and research funding from Astellas Pharma and Boehringer Ingelheim. HP has received speaker honoraria from Janssen, Boehringer Ingelheim and AstraZeneca. BZ has received research support and or consulting honoraria from Boehringer Ingelheim, Janssen, AstraZeneca, Eli Lilly, Novo Nordisk, Merck and Sanofi. RM received research support from Boehringer Ingelheim and honoraria for speaking from Sanofi and Abbott Diabetes Care. None of the above awards or honoraria are directly associated with this specific study. JL and HT have no conflicts of interest to declare. NS, NF, SK, HJW, UCB and OEJ are employees of Boehringer Ingelheim. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.
Author Contributions
Conceived and designed the experiments: BAP DC NS NF SK HJW UCB OEJ. Performed the experiments: BAP DC JL HP HT BZ RM. Analyzed the data: BAP DC JL HP HT BZ RM NS NF SK HJW UCB OEJ. Wrote the paper: BAP DC JL HP HT BZ RM NS NF SK HJW UCB OEJ.